Vincenzo Cuccurullo, M.D., Ph.D.

Vincenzo Cuccurullo, M.D., Ph.D.

Assistant Professor in Diagnostic Imaging at Second University of Naples and Professor of Nuclear Medicine at School of speciality in Radiodiagnostics, Radiotherapy and Nuclear Medicine

  • Biography
  • Research Interests
  • Publications

Dr. Vincenzo Cuccurullo was born in Naples, Italy and received his M.D. degree from the Second University of Naples in 1994 and his experimental thesis was on 111In-Octreotide scintigraphy in Graves’ ophthalmopathy.  At the same university in 1998 he obtained his Specialist in Nuclear Medicine with an experimental thesis on Scintimammography.  In 2002, he was awarded a Ph.D. in Diagnostic Imaging and a component of his research was carried out at the Center of Excellence in Cardiology, Second University of Naples.  Since 2003, Dr. Cuccurullo has been working as a Medical Doctor in Nuclear Medicine at the Second University of Naples and from 2008 as an Assistant Professor in Nuclear Medicine researching in Diagnostic Imaging techniques.  He has been part of several research projects especially in the field of oncology including the use of 99mTc-Tetrofosmin (Myoview) and 99mTc-Sestamibi in oncology.  Other projects including the application of 111In-Octreotide and radioguided surgery (RGS).  Dr. Cuccurullo is the author of more of 150 articles consisting of research papers, abstracts and chapters of books.  He has presented his research (oral presentations and scientific posters) at national and international level, has been an invited speaker at national and international meetings and workshops.  He is a book reviewer for the European J. of Nuclear Medicine and Molecular Imaging and Associate Editor of Current Radiopharmaceuticals.

 

  1. Mansi, P.F. Rambaldi, V. Cuccurullo, A. Laprovitera, F.Di Gregorio, F.Masone, E. Procaccini. 99mTc Tetrofosmin in breast cancer: experience of Second University of Naples. Tumori. 1997; 83: 523-525.
  2. Mansi, P.F. Rambaldi, V. Cuccurullo, B. Pecori, M. Quarantelli, F. Fallanca, E. Del Vecchio. Diagnostic and prognostic role of 99mTc Tetrofosmin in breast cancer. Q J Nucl Med. 1997; 41: 239-250.
  3. Mansi, E. Di Lieto, P.F. Rambaldi, C. Bergaminelli, F. Fallanca, G. Vicidomini, V. Cuccurullo, R. Mancusi. Preliminary experience with radioimmuno-guided surgery of primary neoplasms of the lung. Min Chir. 1998; 53(5): 369-372.
  4. Argenzio, P.F. Rambaldi, G. Iorio, V. Cuccurullo, G.L. Cascini, G. Argenziano, L. Mansi. Radioimmunoguided surgery in squamous cell carcinoma. Plast.Reconstr.Surg. 1999; 103(2): 749-751.
  5. Santini, P.F. Rambaldi, E. Di Lieto, V. Cuccurullo, G. Vicidomini, V.G. Di Crescenzo, L. Mansi, V. Pastore Role of radio-guided surgery with 111In-octreotide in the treatment of thoracic neoplasms. Minerva Endocrinol. 2001; 26(4): 285-288.
  6. L. Cascini, V. Cuccurullo, P.F. Rambaldi, L. Mansi. Immunological imaging using marked octreotide. Minerva Endocrinol. 2001; 26(3): 129-133.
  7. Cuccurullo, G.L. Cascini, P.F. Rambaldi, L. Mansi. Role of somatostatin analogs in the treatment of neuroendocrine tumours. Minerva Endocrinol. 2001; 26(3): 135-143.
  8. Parlato, A. Rosica, V. Cuccurullo, L. Mansi, P. Macchia, J.D. Owens, J.F. Mushinski, M. De Felice, R.F. Bonner, R. Di Lauro. A preservation method that allows recovery of intact RNA from tissues dissected by laser capture microdissection. Anal.Biochem. 2002; 300: 139-145.
  9. Procaccini, R. Ruggiero, L. Mansi, A.P. Laprovitera, P.F. Rambaldi, V. Cuccurullo, F. Procaccini, P. Zenone. Modulation of the axillary lymph node dissection in breast cancer. Ann Ital Chir. 2003; 74: 21-29.
  10. Mansi, R. Moncayo, V. Cuccurullo, E. Dottorini, P.F. Rambaldi. Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Q J Nucl Med. 2004; 48: 82-95.
  11. Mansi, P.F. Rambaldi, V. Cuccurullo, T. Varetto. Nuclear Medicine in emergency. Q J Nucl Med. 2005; 45:171-191.
  12. F. Rambaldi, V. Cuccurullo, V. Briganti, L. Mansi. The present and future role of In111-Pentetreotide in the PET era. Q J Nucl Med. 2005; 49: 225-235.
  13. Cuccurullo, D. Stellato, P.F. Rambaldi, M. Spadafora, N.G. De Santo, M. Cirillo, L. Mansi. Continuous monitoring. Seminars Nephrology. 2006; 26(1): 80-84.
  14. De Falco, D. Parmeggiani, G. Oliva, A. Miranda, A. Di Benedetto, M. Accardo, V. Cuccurullo, L. Mansi, G. Docimo, U. Parmeggiani. Radio-guided surgery in follicular neoplasms of the thyroid. Tumori. 2005; 4(3): 160-167.
  15. Sperlongano, D. Parmeggiani, D. Pisaniello, M. De Falco ,I. Sordelli, M. Accardo, V. Cuccurullo, L. Mansi, G.P. Tartaro, A. Barbarisi, N. Avenia, U. Parmeggiani. Surgical treatment of differentiated thyroid carcinoma: a retrospective study. Front Biosci. 2006; 11: 2206-2212.
  16. Colella, A. Giudice, P.F. Rambaldi, V. Cuccurullo. Parotid function after selective deep lobe parotidectomy. Br J Oral Maxillofac Surg. 2007; 45(2): 108-111.
  17. Maffettone, G. Rossetti, P.F. Rambaldi, F. Russo, V. Cuccurullo, L. Brusciano, G. del Genio, G. Russo, F. Pizza, L. Mansi, A. del Genio. Whole stomach transposition without gastric drainage procedure: a good surgical option to restore digestive continuity after esophagectomy. Int Surg. 2007; 92(2): 73-77.
  18. Ruggiero, E. Procaccini, V. Cuccurullo, L. Mansi, S. Gili, C. Cremone , G. Docimo, L. Docimo, L. Sparavigna, A. Gubitosi, F. Iovino, D. Parmeggiani, N. Avenia. Plurifocal breast cancer and double lymphatic spread. G Chir. 2008; 29(10): 424-426.
  19. Sasso, P.F. Rambaldi, F.S. Sasso, V. Cuccurullo, P. Murino, P. Puntieri, H.R. Marsiglia, L. Mansi Scintigraphic evaluation of oesophageal transit during radiotherapy to the mediastinum. BMC Gastroenterol. 2008; 8: 51.
  20. L. Kitson, V. Cuccurullo, A. Ciarmiello, D. Salvo, L. Mansi. Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology. Curr Radiopharm. 2009; 2: 224-253.
  21. L. Cascini, V. Cuccurullo, L. Mansi. The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology. Q J Nucl Med Mol Imaging. 2010; 54(1): 24-36.
  22. F. Rambaldi, V. Cuccurullo, G.L. Cascini, L. Mansi. Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201Tl-chloride. Eur J Nucl Med Mol Imaging. 2010; 37(8): 1616.
  23. Grassi, P.F. Rambaldi, G. Di Grezia, L. Mansi, V. Cuccurullo, A. Cirillo, G. Riegler, S. Cappabianca, A. Rotondo. Inflammatory bowel disease: value in diagnosis and management of MDCT-enteroclysis and 99mTc-HMPAO labeled leukocyte scintigraphy. Abdom Imaging. 2011; 36(4): 372-381.
  24. L. Cascini, V. Cuccurullo, O. Tamburrini, L. Mansi, A. Rotondo. Nuclear medicine in multiple myeloma – more than diagnosis. Nucl Med Rev Cent East Eur. 2010; 13(1): 32-38.
  25. Cuccurullo, G.L. Cascini, O. Tamburrini, L. Mansi, A. Rotondo. Less frequent requests for In-111 pentreotide and its brothers of endocrinological interest. Minerva Endocrinol. 2011; 36(1): 41-52.
  26. Cuccurullo, G.L. Cascini, A. Rossi, O. Tamburrini, A. Rotondo, L. Mansi. Pathophysiological premises to radiotracers for bone metastases. Q J Nucl Med Mol Imaging. 2011; 55(4): 353-373.
  27. Cuccurullo, L. Mansi Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model. Eur J Nucl Med Mol Imaging. 2012; 39(8): 1262-1265.
  28. Mansi, A. Ciarmiello, V. Cuccurullo. PET/MRI and the revolution of the third eye. Eur J Nucl Med Mol Imaging. 2012; 39(10): 1519-1524.
  29. Stabile Ianora, M. Losco, P. Fonio, P. Zeppa, N.L. Pizza, V. Cuccurullo. Actual role of MRT in the small bowel studies: dynamic sequenze and bowel distension. Rec Prog Med. 2012; 103(11): 422-425.
  30. Gatta, F. Cioce, A. Fontanarosa, A. Raucci, V. Cuccurullo, P. Zeppa, G. Rubini. Inflammatory bowel disease: possibilities and limits in MDCT. Rec Prog Med. 2012; 103(11): 417-421
  31. Cuccurullo, F. Cioce, A. Sica, F. Iasiello, R. Capasso, G. Gatta, G. Rubini. Gastroenteric diseases in the third millennium: a rational approach to optimal imaging technique and patient selection. Rec Prog Med. 2012; 103(11): 426-430.
  32. Scardapane, A. Stabile Ianora, V. Cuccurullo, N.L Pizza, R. Capasso, G. Gatta. Role of nuclear imaging in the management and follow-up of patients with inflammatory bowel disease. Rec Prog Med. 2012; 103(11): 431-434.
  33. Raucci, G. Gatta, V. Cuccurullo. DW-MRI and bone scintigraphy in monitoring radio-therapy response in bone metastases. Rec Prog Med. 2012; 103(11): 438-443.
  34. Cioce, A. Raucci, A. Fontanarosa, N.L Pizza, V. Cuccurullo, A. Stabile Ianora, G. Rubini. Evaluation of the small bowel with computed tomography enteroclysis: technical applications and clinical indications. Recenti Prog Med. 2012; 103(11): 455-458.
  35. Cuccurullo, A. Faggiano, M. Scialpi , G.L. Cascini, A. Piunno, O. Catalano, A. Colao, L. Mansi. Questions & Answers: What can be said by Diagnostic Imaging in neuroendocrine tumors? Minerva Endocrinol. 2012; 37(4): 367-377.
  36. L. Cascini, V. Cuccurullo, O. Tamburrini, A. Rotondo, L. Mansi. Peptide Imaging with Somatostatin Analogues: More than Cancer Probes. Current Radiopharmaceuticals. 2013; 6(1): 36-40.
  37. Cuccurullo, G.L. Cascini, O. Tamburrini, A. Rotondo, L. Mansi. Bone metastases radiopharmaceuticals: an overview. Curr Radiopharm. 2013; 6(1): 41-47.
  38. L. Cascini, V. Cuccurullo, A. Restuccia, O. Tamburrini, A. Rotondo, L.Mansi. Neurological applications for myocardial MIBG scintigraphy. Nuclear Medicine Review Cent East Eur. 2013; 16(1): 35-41.
  39. L. Kitson, V. Cuccurullo, T.S. Moody, L. Mansi. Radionuclide antibody-conjugates, a targeted therapy towards cancer. Curr Radiopharm. 2013; 6(2): 57-71.
  40. L. Cascini, V. Cuccurullo, L. Mansi. 18FNa-fluoride has a higher extraction with respect to 99mTc-methylene diphosphonate: Mismatch in a case of meningioma. Rev Esp Med Nucl Imagen Mol. 2013; (32) Aug 31.
  41. Cuccurullo, G.L. Cascini, L. Mansi. Structural, pathophysiological and clinical aspects of diagnostic imaging in breast recurrence: the breast after treatment. Q J Nucl.Medicine Mol.Imaging. 2013; 57: 322-331.
  42. Lupi, G. Bertagnoni, A. Borghero, A. Picelli, V. Cuccurullo, P. Zanco. 18FDG-PET/CT in Traumatic Brain Injury Patients: The Relative Hypermetabolism of Vermis Cerebelli as a Medium and Long Term Predictor of Outcome. Curr Radiopharm. 2014; 7(1): 57-62.
  43. Mansi, V. Cuccurullo, A. Ciarmiello. From Homo sapiens to Homo in nexu (connected man): could functional imaging redefine the brain of a “new human species”? Eur J Nucl Med Mol Imaging. 2014; 41(7): 1385-1387.
  44. Cistaro, V. Cuccurullo, N. Quartuccio, M. Pagani, M.C. Valentini, L. Mansi. Role of PET and SPECT in the study of amyotrophic lateral sclerosis. Biomed Res Int. 2014; 2014:
  45. Mansi, V. Cuccurullo, L. Evangelista. Is Radiocholine PET/CT Already Clinically Useful in Patients with Prostate Cancer? J Nucl Med. 2014; 55(9): 1401-1403.
  46. Ciarmiello, E. Giovannini, M. Meniconi, V. Cuccurullo, M.C. Gaeta. Hybrid SPECT/CT Imaging in Neurology. Curr Radiopharm. 2014; 7(1): 5-11.